Correlation Engine 2.0
Clear Search sequence regions


  • alpha lipoic acid (1)
  • capsaicin (3)
  • clonazepam (3)
  • dentists (1)
  • humans (1)
  • kinds (1)
  • light (1)
  • low (2)
  • mouth (10)
  • oral mucosa (1)
  • oral pain (2)
  • patients (1)
  • periods (1)
  • tongue (1)
  • Sizes of these terms reflect their relevance to your search.

    Burning mouth syndrome (BMS) is idiopathic chronic oral pain, associated with depression, anxiety and pain symptoms. The BMS symptoms include a burning sensation in the tongue and/or other oral mucosa with no underlying medical or dental reasons. As many BMS patients suffer from psychiatric comorbidities, several psychotropic drugs are included in the management of BMS, reducing the complaint, while managing anxiety, depression and pain disorders. In this review, a search of the published literature regarding the management of BMS was conducted. We discuss the BMS etiology, clinically associated symptoms and available treatment options. The current evidence supports some BMS interventions, including alpha-lipoic acid (ALA), clonazepam, capsaicin, and low-level laser therapy (LLLT); however, there is a lack of robust scientific evidence, and large-scale clinical trials with long follow-up periods are needed to establish the role of these BMS management options. This knowledge could raise the awareness of dentists, psychiatrists and general practitioners about these challenges and the available kinds of treatment to improve multidisciplinary management for better health outcomes.

    Citation

    Ayman Antoun Reyad, Raafat Mishriky, Eriny Girgis. Pharmacological and non-pharmacological management of burning mouth syndrome: A systematic review. Dental and medical problems. 2020 Jul-Sep;57(3):295-304

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33113291

    View Full Text